The PROTECTｩ Trial

Targeted Number of Patients:Approximately 3,000 at  centers in the US, Canada, UK, Continental Europe and Australia

Treatment Arms:

1. Oral solution: SNAC/Heparin 60K Us (12 mls)

• 2. Oral solution: SNAC/Heparin 90K Us (18 mls)

• 3. Injection: enoxaparin 30mg, and oral placebo

Oral Heparin Solution

Previous slide

Next slide

Back to first slide

View graphic version